Hemispherx Biopharma, Inc. has completed its new manufacturing site in New Brunswick, NJ, which now encompasses more than 43,000 sq.-ft. The $8 million in upgrades provides higher capacity and a more cost effective manufacturing process for Alferon N Injection, which is the only FDA-approved natural alpha interferon.   The company was able to increase efficiency by integrating continuous flow manufacturing technology throughout the process, improving costs, enhancing yields, real-time process mo...